Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xtacy Therapeutics (TSE:LOAN)
CNQX:LOAN
Holding TSE:LOAN?
Track your performance easily
LOAN Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.10
Previous CloseC$0.03
VolumeN/A
Average Volume (3M)143.37K
Market Cap
N/A
Enterprise ValueC$1.76M
Total Cash (Recent Filing)C$0.00
Total Debt (Recent Filing)C$17.57K
Price to Earnings (P/E)―
Beta2.44
Next Earnings
Jan 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding58,156,971
10 Day Avg. Volume29,564
30 Day Avg. Volume143,374
Standard Deviation0.37
R-Squared0.00699
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-3.00
Price to Sales (P/S)30.22
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xtacy Therapeutics News
PremiumCompany Announcements
Pegasus Mercantile Enhances Beverage Unit with Strategic Advisory Appointment
PremiumCompany Announcements
Pegasus Mercantile Expands with New Subsidiaries
PremiumCompany Announcements
Xtacy Therapeutics Rebrands to Pegasus Mercantile
PremiumCompany Announcements
Xtacy Therapeutics Rebrands to Pegasus Mercantile
PremiumCompany Announcements
Xtacy Therapeutics Welcomes New Board Member
PremiumCompany Announcements
Xtacy Therapeutics Optimizes Finances with Equity
PremiumCompany Announcements
Xtacy Therapeutics Advances with Debt Settlement and Research
PremiumCompany Announcements
Xtacy Therapeutics Resolves Filing DelayLOAN FAQ
What was Xtacy Therapeutics’s price range in the past 12 months?
Xtacy Therapeutics lowest stock price was C$0.01 and its highest was C$0.10 in the past 12 months.
What is Xtacy Therapeutics’s market cap?
Currently, no data Available
When is Xtacy Therapeutics’s upcoming earnings report date?
Xtacy Therapeutics’s upcoming earnings report date is Jan 29, 2025 which is in 19 days.
How were Xtacy Therapeutics’s earnings last quarter?
Xtacy Therapeutics released its earnings results on Aug 26, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Xtacy Therapeutics overvalued?
According to Wall Street analysts Xtacy Therapeutics’s price is currently same.
Does Xtacy Therapeutics pay dividends?
Xtacy Therapeutics does not currently pay dividends.
What is Xtacy Therapeutics’s EPS estimate?
Xtacy Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xtacy Therapeutics have?
Xtacy Therapeutics has 58,156,970 shares outstanding.
What happened to Xtacy Therapeutics’s price movement after its last earnings report?
Xtacy Therapeutics reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Xtacy Therapeutics?
Currently, no hedge funds are holding shares in TSE:LOAN
---
Company Description
Xtacy Therapeutics
Redfund Capital Corp is a debt financing company. The company provides debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It is focusing on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.
---
Technical Analysis
Spyre Therapeutics
―
Bio-Path Holdings
―
Xtacy Therapeutics
―
Akari Therapeutics
―
---